ImmunityBio, Inc. , a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access program (EAP) that will bring a vital alternative ...

The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S. bladder cancer patient registry at the 2025 American Society of Clinical ...

"The breadth and depth of Decipher-focused data presented at the ASCO GU Symposium reinforce the widespread impact our Decipher tests are having on clinical care, as well as on research into the ...

NEW YORK & TOKYO - Pfizer Inc. (NYSE: NYSE:PFE) and Astellas Pharma Inc. (TSE: TYO:4503) have announced updated results from the Phase 3 EV-302 clinical trial, which showed that the combination of ...

Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements, including, but not limited to our statements related to the potential for the use of the ...

Nonintravesical Interventions for Preventing Intravesical Recurrence in Patients With Nonmuscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. February 16, 2025 Circulating tumor DNA ...

IBS and bladder problems may be linked according to research. Bladder issues, like frequent urination, are commonly diagnosed in addition to irritable bowel syndrome (IBS). The overlap between bladder ...

The Associated Press won the 2024 Pulitzer Prize for Feature Photography for its compelling, multi-country photojournalism showing migration from Central America to the United States. Get a behind-the ...

CystoSmart™ is an image enhancement and AI diagnostic tool designed and developed to detect bladder cancer. This AI detection software supports clinicians in interpreting images and videos of ...